Rituximab, Pentostatin, Cyclophosphamide, and Lenalidomide in Treating Patients With Previously Untreated B-Cell Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Condition(s):Leukemia; LymphomaLast Updated:January 27, 2020Completed
Hide Studies Not Open or Pending
Condition(s):Leukemia; LymphomaLast Updated:January 27, 2020Completed
Condition(s):Chronic Lymphocytic Leukemia; Stage 0 Chronic Lymphocytic Leukemia; Stage I Chronic Lymphocytic Leukemia; Stage I Small Lymphocytic Lymphoma; Stage II Chronic Lymphocytic Leukemia; Stage II Small Lymphocytic Lymphoma; Stage III Chronic Lymphocytic Leukemia; Stage III Small Lymphocytic Lymphoma; Stage IV Chronic Lymphocytic Leukemia; Stage IV Small Lymphocytic LymphomaLast Updated:September 18, 2018Completed
Condition(s):Chronic Lymphocytic LeukemiaLast Updated:August 18, 2005Unknown status
Condition(s):Leukemia; LymphomaLast Updated:February 4, 2013Completed
Condition(s):Leukemia; LymphomaLast Updated:May 12, 2016Completed
Condition(s):Leukemia; LymphomaLast Updated:June 25, 2013Completed
Condition(s):Recurrent Severe Aplastic Anemia; Refractory Severe Aplastic AnemiaLast Updated:December 22, 2023Recruiting
Condition(s):Graft vs Host Disease; Immune System DisordersLast Updated:November 1, 2021Completed
Condition(s):LeukemiaLast Updated:January 11, 2019Completed
Condition(s):Leukemia; LymphomaLast Updated:May 12, 2011Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.